Schlieren
A candid, nohype session on current AI adoption, with a particular focus on Pharma R&D. We’ll ground the discussion in what’s feasible in 2025, separating what delivers impact from what does not. Expect practical lessons on moving from pilot to validated use, controls that satisfy QA/RA, and mistakes to avoid, from leading players in the field like Roche, JNJ and AWS. Attendees leave with clear, actionable takeaways they can apply the next day.
What you’ll learn
Where teams are seeing measurable operational value today
Minimum readiness to scale (data, validation, audit trail, change control)
Guardrails that keep QA/RA comfortable (explainability, monitoring, rollback)
Adoption lessons across roles/skills and partnering models
Who should attend
Leaders in pharma R&D or interested in AI. To ensure a meaningful experience for all attendees, participation is by invitation or approved registration. Zühlke will be reviewing all registrations to ensure they align with the event’s focus and audience. Once your place has been confirmed, you’ll receive a confirmation email.
Agenda
5.00pm Registration
5.30pm Opening remarks by Daniel Wilhelm, Managing Director Health Industry EMEA & Partner, Zühlke
5.35pm Lightning talk by Scott Oloff, JNJ
Scott will showcase a real-world AI application developed at Roche for clinical development in ophthalmology, sharing key insights and lessons learned.5.50pm Moderated panel discussion with Tasio Guevara (AWS), Scott Oloff (JNJ) and Gabriel Krummenacher (Zühlke), followed by audience Q&A
The panel discussion will explore how AI can be scaled within the pharmaceutical industry, examining practical applications, the translation of innovative pilots into scalable solutions, and the data science challenges that must be addressed to ensure responsible implementation.6:30pm Closing remarks by Daniel Wilhelm followed by a lab visit and Apéro
If you have questions about the event, please contact Christian Hein (christian.hein@zuhlke.com)